| Name | Title | Contact Details |
|---|
RaNA Therapeutics is pioneering the discovery of a new class of RNA-targeted medicines that selectively activate protein expression within the body`s own cells. By targeting specific genes, RaNA`s novel drugs work epigenetically to precisely upregulate the expression of beneficial proteins in order to treat or prevent disease. The company`s leadership leverages preeminent founders and advisors in the field, and the strength of its fundamental patents, technology, and know-how that underlie the discovery and development of therapeutics that selectively activate RNA. RaNA is applying its proprietary technology to rapidly advance a pipeline of novel drugs for diverse therapeutic areas, with an initial emphasis in the fields of rare genetic disorders, inflammation, oncology, metabolic diseases and neurodegenerative diseases.
Blue Ridge HealthCare Systems is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Blue Ridge HealthCare Systems is based in Morganton, NC. You can find more information on Blue Ridge HealthCare Systems at www.blueridgehealth.org
At Matrix, we understand that access to care often translates to quality of care. In 2007, we broke the mold on the traditional physician office visit care model, and decided that the best place for care is in the home. That`s why we pioneered the use of Nurse Practitioners to visit health plan members where they needed care the most—in their home or a nursing facility. It is this pioneering attitude that has helped us continue to innovate the way care is delivered. With advanced technology, innovative solutions, highly skilled Nurse Practitioners and exceptional processes, Matrix excels at delivering the right care, at the right place, by the right person…every time. We are changing the way healthcare is delivered.
Data R X Management is a Cumming, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Based in Redmond, WA, EndoGastric Solutions, Inc., is a medical device company focused on developing and commercializing innovative, evidence-based, incisionless surgical technology for the treatment of gastroesophageal reflux disease (GERD). EGS has combined the most advanced concepts in gastroenterology and surgery to develop the Transoral Incisionless Fundoplication (TIF®) procedure—a minimally invasive solution that addresses a significant unmet clinical need.